Andrew Hill Investment Advisors Inc. Invests $338,000 in Stryker Corporation $SYK

Key Points

• Andrew Hill Investment Advisors Inc. has invested approximately $338,000 in Stryker Corporation, acquiring 854 shares during the second quarter.
• Insider Viju Menon sold 500 shares for around $195,305, while Director Ronda E. Stryker sold 200,000 shares for $75.29 million, indicating a decrease in their holdings.
• Stryker's recent quarter earnings surpassed estimates, with $3.13 EPS and $6.02 billion in revenue, leading analysts to raise their price targets for the stock.

Andrew Hill Investment Advisors Inc. purchased a new position in shares of Stryker Corporation (NYSE:SYK - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 854 shares of the medical technology company's stock, valued at approximately $338,000.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Family Legacy Financial Solutions LLC acquired a new stake in shares of Stryker during the 2nd quarter worth approximately $4,284,000. Wealth Enhancement Advisory Services LLC raised its stake in Stryker by 6.9% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 147,884 shares of the medical technology company's stock valued at $58,456,000 after acquiring an additional 9,528 shares in the last quarter. Strathmore Capital Advisors Inc. acquired a new position in Stryker during the 2nd quarter worth $552,000. Mn Services Vermogensbeheer B.V. grew its stake in shares of Stryker by 2.5% in the second quarter. Mn Services Vermogensbeheer B.V. now owns 128,400 shares of the medical technology company's stock worth $50,799,000 after purchasing an additional 3,100 shares in the last quarter. Finally, Wedmont Private Capital increased its holdings in shares of Stryker by 8.1% during the second quarter. Wedmont Private Capital now owns 4,189 shares of the medical technology company's stock valued at $1,642,000 after purchasing an additional 313 shares during the period. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the stock. Citigroup reaffirmed a "buy" rating and issued a $455.00 price objective (up previously from $443.00) on shares of Stryker in a report on Thursday, May 22nd. Evercore ISI upped their price target on shares of Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 8th. Truist Financial set a $415.00 price objective on shares of Stryker and gave the company a "hold" rating in a research note on Monday, August 4th. Wells Fargo & Company increased their price target on Stryker from $435.00 to $445.00 and gave the company an "overweight" rating in a research note on Friday, August 1st. Finally, Rothschild & Co Redburn initiated coverage on Stryker in a research note on Thursday. They issued a "neutral" rating and a $420.00 price objective on the stock. Fourteen analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus price target of $430.33.

Stryker Price Performance

Shares of SYK traded down $1.23 during trading hours on Friday, hitting $376.61. 1,924,253 shares of the company were exchanged, compared to its average volume of 934,259. The company has a market capitalization of $143.98 billion, a PE ratio of 49.88, a PEG ratio of 2.72 and a beta of 0.93. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.06. The firm has a fifty day simple moving average of $387.52 and a 200-day simple moving average of $379.19. Stryker Corporation has a one year low of $329.16 and a one year high of $406.19.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating the consensus estimate of $3.07 by $0.06. The business had revenue of $6.02 billion during the quarter, compared to the consensus estimate of $5.92 billion. Stryker had a return on equity of 23.94% and a net margin of 12.25%.Stryker's revenue was up 11.1% compared to the same quarter last year. During the same period in the prior year, the business posted $2.81 earnings per share. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, sell-side analysts predict that Stryker Corporation will post 13.47 earnings per share for the current year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Tuesday, September 30th will be issued a dividend of $0.84 per share. This represents a $3.36 annualized dividend and a yield of 0.9%. The ex-dividend date is Tuesday, September 30th. Stryker's payout ratio is presently 44.50%.

Insider Activity

In other Stryker news, insider Viju Menon sold 500 shares of the business's stock in a transaction dated Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares in the company, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Ronda E. Stryker sold 200,000 shares of the firm's stock in a transaction on Wednesday, August 6th. The stock was sold at an average price of $376.45, for a total value of $75,290,000.00. Following the completion of the sale, the director directly owned 3,222,108 shares of the company's stock, valued at approximately $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The disclosure for this sale can be found here. 5.90% of the stock is currently owned by insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.